Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 66.10
-1.60 (-2.36%)
Oct 28, 2025, 4:08 PM HKT
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 24.33 billion as of October 29, 2025. Its market cap has increased by 87.14% in one year.
Market Cap
24.33B
Enterprise Value
24.40B
Revenue
428.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
66.10
Market Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 24.33B, an increase of 220.62%. That is a compound annual growth rate of 21.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 24.33B | 72.89% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | 8.50B | 39.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 269.73B |
| Hansoh Pharmaceutical Group Company | 210.92B |
| JD Health International | 201.53B |
| WuXi Biologics | 151.53B |
| Innovent Biologics | 147.53B |
| Sino Biopharmaceutical | 126.75B |
| Akeso | 106.48B |
| Sichuan Kelun-Biotech Biopharmaceutical | 100.18B |